JAZZHealthcareLarge-Cap

Jazz Pharmaceuticals plc Insider Trading Activity

Every SEC Form 4 insider transaction reported for Jazz Pharmaceuticals plc (JAZZ), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are JAZZ insiders buying or selling?

Jazz Pharmaceuticals plc insiders reported 4 open-market buys ($24.2M) and 258 sells ($154.7M) across 262 Form 4 filings — a net selling position of $130.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Sep 2, 2026)

Total Form 4 filings
262
SEC EDGAR
Insider filers
29
Insider buys (4)
$24.2M
Insider sells (258)
$154.7M

Insider sentiment

Net selling

Net insider flow of $130.5M in net selling.

Recent JAZZ insider transactions

DateInsiderRoleTypeSharesPriceValue
Sep 2, 2026Bruce C CozaddDirectorSale6.0K$250.13$1.5M
Aug 31, 2026Robert IannoneEVP, Global Head of R&D & CMOSale76.9K$249.70$19.2M
Aug 5, 2026Bruce C CozaddDirectorSale6.0K$252.98$1.5M
Jul 6, 2026Bruce C CozaddDirectorSale6.0K$240.47$1.4M
Jun 17, 2026Mark Douglas SmithDirectorSale1.2K$230.55$266.7K
Jun 12, 2026Neena M PatilEVP & Chief Legal OfficerSale1.2K$231.83$278.2K
Jun 3, 2026Bruce C CozaddDirectorSale6.0K$235.12$1.4M
Jun 1, 2026Neena M PatilEVP & Chief Legal OfficerSale1.2K$236.97$282.5K
Jun 1, 2026Samantha PearceEVP, Chief Commercial OfficerSale6.9K$235.41$1.6M
May 27, 2026Rick E WinninghamDirectorSale2.7K$241.57$662.1K
May 27, 2026Heather Ann McsharryDirectorSale2.0K$241.00$482.0K
May 5, 2026Bruce C CozaddDirectorSale6.0K$203.33$1.2M
Apr 3, 2026Bruce C CozaddDirectorSale6.0K$190.50$1.1M
Mar 9, 2026Patricia CarrSVP, Chief Accounting OfficerSale1.3K$182.94$235.4K
Mar 4, 2026Bruce C CozaddDirectorSale6.0K$186.44$1.1M
Mar 2, 2026Norbert G RiedelDirectorSale3.4K$192.00$655.7K
Mar 2, 2026Patricia CarrSVP, Chief Accounting OfficerSale2.4K$192.60$456.5K
Mar 2, 2026Neena M PatilEVP & Chief Legal OfficerSale55.6K$191.56$10.7M
Mar 2, 2026Mary Elizabeth HendersonSVP, Technical OperationsSale5.3K$194.49$1.0M
Dec 11, 2025Mary Elizabeth HendersonSVP, Technical OperationsSale2.2K$169.51$379.4K
Dec 9, 2025Patricia CarrSVP, Chief Accounting OfficerSale4.7K$171.20$797.8K
Dec 1, 2025Bruce C CozaddDirectorSale77.5K$177.81$13.8M
Nov 24, 2025Heather Ann McsharryDirectorSale3.4K$177.78$607.1K
Nov 21, 2025Bruce C CozaddDirectorSale18.0K$181.09$3.3M
Nov 20, 2025Patricia CarrSVP, Chief Accounting OfficerSale5.3K$182.06$968.4K

Showing the 25 most recent of 262 Form 4 filings for Jazz Pharmaceuticals plc.

Most active JAZZ insiders

  • Bruce C Cozadd69 filings
  • Patricia Carr28 filings
  • Matthew P. Young15 filings
  • Michael Patrick Miller15 filings
  • Neena M Patil12 filings

Ask anything about JAZZ insider activity

Use Trabud's AI agent to query Jazz Pharmaceuticals plc's Form 4 history in plain English — "Show me JAZZ CEO purchases this year" or compare it against any other ticker.

Open the AI agent

JAZZ insider trading FAQ

Are Jazz Pharmaceuticals plc insiders buying or selling?

Across 262 SEC Form 4 filings, Jazz Pharmaceuticals plc (JAZZ) insiders reported 4 open-market purchases totaling $24.2M and 258 sales totaling $154.7M. That is a net selling position of $130.5M.

How many insiders trade JAZZ stock?

29 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Jazz Pharmaceuticals plc. The most recent filing was accepted on Sep 2, 2026.

Where does Trabud get JAZZ insider trading data?

All JAZZ insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content